Cynata Therapeutics Limited(CYYNF)
$0.01+0.01 (+457.71%)
CYYNF
Cynata Therapeutics Limited financials statements
$0.01
At close:+0.01 (+457.71%)
Cynata Therapeutics Limited (CYYNF) Ratios
6 Followers
Cynata Therapeutics Limited Ratios
CYYNF's free cash flow for Q4 2026 was AU$-4.35M. For the 2026 fiscal year, CYYNF's free cash flow was increased by AU$0.00 and operating cash flow was AU$-4.35M. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.64 | 4.40 | 5.58 | 7.46 | 9.33 |
| Quick Ratio | 0.64 | 4.40 | 5.58 | 7.46 | 9.33 |
| Cash Ratio | 0.51 | 4.15 | 5.30 | 7.15 | 9.20 |
| Solvency Ratio | -5.14 | -7.49 | -8.08 | -6.19 | -2.00 |
| Operating Cash Flow Ratio | -3.85 | -7.17 | -8.51 | -6.32 | -1.27 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | AU$ -629.21K | AU$ 4.13M | AU$ 5.37M | AU$ 14.60M | AU$ 21.55M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -3.44 | 1.20 | 1.16 | 1.14 | 1.11 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.10 | 0.54 | 0.62 | 1.03 | 3.97 |
| Profitability Margins | |||||
| Gross Profit Margin | -15.21% | 100.00% | 100.00% | 83.08% | 96.40% |
| EBIT Margin | -565.83% | -509.82% | -441.79% | -963.05% | -80.79% |
| EBITDA Margin | -550.62% | -494.81% | -429.70% | -946.13% | -77.19% |
| Operating Profit Margin | -565.83% | -430.95% | -380.37% | -999.96% | -88.80% |
| Pretax Profit Margin | -640.36% | -498.14% | -520.82% | -963.05% | -80.79% |
| Net Profit Margin | -540.36% | -498.14% | -420.82% | -863.05% | -70.08% |
| Continuous Operations Profit Margin | -540.36% | -398.14% | -420.82% | -863.05% | -70.08% |
| Net Income Per EBT | 84.38% | 100.00% | 80.80% | 89.62% | 86.74% |
| EBT Per EBIT | 113.17% | 115.59% | 136.93% | 96.31% | 90.98% |
| Return on Assets (ROA) | -682.77% | -130.46% | -116.17% | -75.17% | -20.51% |
| Return on Equity (ROE) | 2345.99% | -156.99% | -135.02% | -85.32% | -22.73% |
| Return on Capital Employed (ROCE) | 2456.58% | -135.81% | -122.04% | -98.86% | -28.80% |
| Return on Invested Capital (ROIC) | 2072.95% | -108.55% | -98.61% | -88.59% | -24.98% |
| Return on Tangible Assets | -826.06% | -175.56% | -149.08% | -84.68% | -22.56% |
| Earnings Yield | -279.10% | -30.55% | -18.39% | -78.72% | -10.56% |
| Efficiency Ratios | |||||
| Receivables Turnover | 24.26 | 18.01 | 20.46 | 4.51 | 77.40 |
| Payables Turnover | 0.26 | 0.72 | 0.65 | 0.21 | 0.18 |
| Inventory Turnover | 0.00 | 0.00 | -78.68 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 1.26 | 0.26 | 0.28 | 0.09 | 0.29 |
| Working Capital Turnover Ratio | 0.98 | 0.40 | 0.23 | 0.09 | 0.33 |
| Cash Conversion Cycle | -1410.94 | -487.83 | -548.33 | -1625.13 | -2055.81 |
| Days of Sales Outstanding | 15.04 | 20.26 | 17.84 | 80.99 | 4.72 |
| Days of Inventory Outstanding | 0.00 | 0.00 | -4.64 | 0.00 | 0.00 |
| Days of Payables Outstanding | 1425.98 | 508.09 | 561.54 | 1706.12 | 2060.52 |
| Operating Cycle | 15.04 | 20.26 | 13.20 | 80.99 | 4.72 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.03 | -0.04 | -0.06 | -0.10 | -0.02 |
| Free Cash Flow Per Share | -0.03 | -0.04 | -0.06 | -0.10 | -0.02 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -174.41 | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | -174.41 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | -3.94 | -4.63 | -4.30 | -8.63 | -0.42 |
| Free Cash Flow Yield | -203.26% | -28.53% | -18.80% | -78.75% | -6.39% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.36 | -3.28 | -5.44 | -1.27 | -9.47 |
| Price-to-Sales (P/S) Ratio | 1.94 | 16.31 | 22.88 | 10.96 | 6.64 |
| Price-to-Book (P/B) Ratio | -8.41 | 5.14 | 7.34 | 1.08 | 2.15 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.49 | -3.51 | -5.32 | -1.27 | -15.64 |
| Price-to-Operating Cash Flow Ratio | -0.49 | -3.53 | -5.32 | -1.27 | -15.64 |
| Price-to-Earnings Growth (PEG) Ratio | 0.02 | 0.21 | 0.12 | -0.01 | 0.27 |
| Enterprise Value Multiple | -0.26 | -2.75 | -4.70 | -0.13 | -4.63 |
| Enterprise Value | 2.42M | 25.69M | 46.79M | 1.97M | 27.78M |
| EV to EBITDA | -0.26 | -2.75 | -4.70 | -0.13 | -4.63 |
| EV to Sales | 1.41 | 13.63 | 20.20 | 1.19 | 3.58 |
| EV to Free Cash Flow | -0.36 | -2.93 | -4.70 | -0.14 | -8.42 |
| EV to Operating Cash Flow | -0.36 | -2.95 | -4.70 | -0.14 | -8.42 |
| Tangible Book Value Per Share | -0.00 | 0.02 | 0.03 | 0.10 | 0.15 |
| Shareholders’ Equity Per Share | -0.00 | 0.03 | 0.04 | 0.12 | 0.17 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.16 | 0.20 | 0.19 | 0.10 | 0.13 |
| Revenue Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.05 |
| Net Income Per Share | -0.04 | -0.05 | -0.05 | -0.10 | -0.04 |
| Tax Burden | 0.84 | 1.00 | 0.81 | 0.90 | 0.87 |
| Interest Burden | 1.13 | 0.98 | 1.18 | 1.00 | 1.00 |
| Research & Development to Revenue | 2.90 | 4.07 | 3.75 | 7.49 | 1.14 |
| SG&A to Revenue | 1.16 | 1.24 | 0.00 | 1.92 | 0.51 |
| Stock-Based Compensation to Revenue | 0.08 | 0.14 | 0.00 | 0.20 | 0.13 |
| Income Quality | 0.74 | 0.93 | 1.02 | 1.00 | 0.61 |
Currency in AUD
